Enter your email to receive notifications about memory_loss and other clinical trials.

Search Results from Clinical Connection

25 studies

Randomized, double-blind, placebo-controlled, parallel-group, 18-month safety and Efficacy study of Leuco-methylthioninium bis(hydromethanesulfonate) in subjects with mild Alzheimer’s disease. ...

Mild to moderate Alzheimer's disease or memory loss.

The TOMMORROW study seeks to learn more about the genetic risk for developing mild cognitive impairment due to Alzheimer’s disease (MCI due to AD) and whether an investigational medication might prov...

Are you beginning to experience a decline in your memory and thinking skills?

California Neuroscience Research is conducting a research study on dementia caused by early Alzheim...

The study is for individuals with Alzheimer's Disease or mild cognitive impairment due to Alzheimer's Disease. The study lasts 18 months with an optional 24 month long-term extension. The study inc...

Hassman Research Institute is conducting a clinical research study for men and women who have mild to moderate Alzheimer's Disease or Memory loss, Doctors are studying a new investigational medicatio...

NeuroStudies.net is conducting a Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy And Safety Study of Crenezumab in Patients With Prodromal to Mild Alzhe...

Longitudinal Evaluation of [18F]MNI-798 as a PET Radioligand for Imaging Tau in the Brain of Patients With Prodromal, Mild, and Moderate Alzheimer's Disease Compared to Healthy Volunteers...

<123>